ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/05/11 | 1,046 | 1,065 | 1,012 | 1,052 | +8 | +0.8% | 571,800 |
| 2022/05/10 | 1,038 | 1,052 | 1,018 | 1,044 | -11 | -1% | 645,500 |
| 2022/05/09 | 1,088 | 1,102 | 1,051 | 1,055 | -53 | -4.8% | 648,500 |
| 2022/05/06 | 1,140 | 1,140 | 1,102 | 1,108 | -41 | -3.6% | 535,700 |
| 2022/05/02 | 1,145 | 1,160 | 1,130 | 1,149 | -1 | -0.1% | 266,900 |
| 2022/04/28 | 1,156 | 1,181 | 1,141 | 1,150 | -6 | -0.5% | 333,300 |
| 2022/04/27 | 1,156 | 1,165 | 1,135 | 1,156 | -40 | -3.3% | 526,600 |
| 2022/04/26 | 1,207 | 1,213 | 1,180 | 1,196 | +5 | +0.4% | 331,400 |
| 2022/04/25 | 1,195 | 1,215 | 1,179 | 1,191 | -30 | -2.5% | 638,900 |
| 2022/04/22 | 1,227 | 1,240 | 1,206 | 1,221 | -33 | -2.6% | 469,900 |
| 2022/04/21 | 1,288 | 1,300 | 1,251 | 1,254 | -34 | -2.6% | 474,800 |
| 2022/04/20 | 1,315 | 1,317 | 1,281 | 1,288 | -12 | -0.9% | 264,200 |
| 2022/04/19 | 1,315 | 1,319 | 1,294 | 1,300 | -5 | -0.4% | 226,000 |
| 2022/04/18 | 1,294 | 1,318 | 1,291 | 1,305 | ±0 | ±0% | 288,900 |
| 2022/04/15 | 1,315 | 1,338 | 1,287 | 1,305 | -27 | -2% | 463,900 |
| 2022/04/14 | 1,313 | 1,344 | 1,293 | 1,332 | +32 | +2.5% | 452,500 |
| 2022/04/13 | 1,301 | 1,329 | 1,297 | 1,300 | +6 | +0.5% | 475,400 |
| 2022/04/12 | 1,294 | 1,312 | 1,264 | 1,294 | -30 | -2.3% | 472,100 |
| 2022/04/11 | 1,331 | 1,339 | 1,291 | 1,324 | -22 | -1.6% | 424,900 |
| 2022/04/08 | 1,378 | 1,378 | 1,335 | 1,346 | -19 | -1.4% | 328,000 |
| 2022/04/07 | 1,410 | 1,419 | 1,356 | 1,365 | -75 | -5.2% | 567,800 |
| 2022/04/06 | 1,430 | 1,460 | 1,423 | 1,440 | -19 | -1.3% | 321,900 |
| 2022/04/05 | 1,430 | 1,474 | 1,413 | 1,459 | +53 | +3.8% | 605,100 |
| 2022/04/04 | 1,385 | 1,406 | 1,366 | 1,406 | +21 | +1.5% | 275,900 |
| 2022/04/01 | 1,395 | 1,397 | 1,364 | 1,385 | -8 | -0.6% | 298,000 |
| 2022/03/31 | 1,382 | 1,403 | 1,370 | 1,393 | +3 | +0.2% | 238,500 |
| 2022/03/30 | 1,413 | 1,425 | 1,380 | 1,390 | +7 | +0.5% | 472,500 |
| 2022/03/29 | 1,352 | 1,393 | 1,352 | 1,383 | +35 | +2.6% | 379,400 |
| 2022/03/28 | 1,380 | 1,384 | 1,332 | 1,348 | -59 | -4.2% | 566,600 |
| 2022/03/25 | 1,457 | 1,461 | 1,342 | 1,407 | -38 | -2.6% | 998,500 |
| 2022/03/24 | 1,386 | 1,456 | 1,384 | 1,445 | +29 | +2% | 705,900 |
| 2022/03/23 | 1,381 | 1,425 | 1,375 | 1,416 | +65 | +4.8% | 796,600 |
| 2022/03/22 | 1,301 | 1,400 | 1,294 | 1,351 | +26 | +2% | 675,400 |
| 2022/03/18 | 1,272 | 1,331 | 1,260 | 1,325 | +56 | +4.4% | 775,900 |
| 2022/03/17 | 1,243 | 1,281 | 1,232 | 1,269 | +61 | +5% | 775,100 |
| 2022/03/16 | 1,241 | 1,246 | 1,188 | 1,208 | -5 | -0.4% | 711,200 |
| 2022/03/15 | 1,255 | 1,259 | 1,205 | 1,213 | -86 | -6.6% | 741,300 |
| 2022/03/14 | 1,283 | 1,307 | 1,275 | 1,299 | +18 | +1.4% | 426,800 |
| 2022/03/11 | 1,290 | 1,312 | 1,255 | 1,281 | -24 | -1.8% | 707,100 |
| 2022/03/10 | 1,332 | 1,336 | 1,294 | 1,305 | +18 | +1.4% | 555,800 |
| 2022/03/09 | 1,362 | 1,367 | 1,282 | 1,287 | -61 | -4.5% | 898,100 |
| 2022/03/08 | 1,380 | 1,430 | 1,334 | 1,348 | -29 | -2.1% | 1,273,200 |
| 2022/03/07 | 1,390 | 1,415 | 1,346 | 1,377 | -59 | -4.1% | 955,600 |
| 2022/03/04 | 1,428 | 1,445 | 1,370 | 1,436 | -21 | -1.4% | 1,305,900 |
| 2022/03/03 | 1,475 | 1,483 | 1,434 | 1,457 | -14 | -1% | 1,170,300 |
| 2022/03/02 | 1,393 | 1,483 | 1,380 | 1,471 | +38 | +2.7% | 1,666,600 |
| 2022/03/01 | 1,446 | 1,462 | 1,392 | 1,433 | +167 | +13.2% | 2,780,500 |
| 2022/02/28 | 1,158 | 1,278 | 1,158 | 1,266 | +81 | +6.8% | 1,339,000 |
| 2022/02/25 | 1,132 | 1,191 | 1,106 | 1,185 | +134 | +12.7% | 1,376,300 |
| 2022/02/24 | 1,095 | 1,099 | 1,033 | 1,051 | -67 | -6% | 1,533,100 |
651～
700
件表示中 / 3611件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 361,000円 | +52.1% | +23.3% | - | - | - |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 科研薬 | 450,000円 | +22.8% | +113.0% | - | - | - |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 417,000円 | +14.5% | -2.3% | - | - | - |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 333,000円 | +15.0% | -7.3% | - | - | - |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 鳥居薬 | 469,500円 | +12.0% | +28.1% | - | - | - |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム
